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Alzheimer‘s disease (AD) is a complex neurodegenerative disorder, which involves 
gradual loss of episodic memory and impairment of cognitive functions. Characteristic 
histopathological hallmarks of AD are neuritic plaques and neurofibrillary tangles  present 
in brain tissue as well as deterioration of cholinergic neurotransmission. Currently there 
are only two classes of drugs used for the treatment of AD. The first group represents 
inhibitors of acetylcholinesterase (AChEI), whereas the second only memantin, NMDA 
receptor antagonist. The aim of the thesis was to synthesize three series of tacrine - 
trolox derivatives. In particular derivatives of trolox with tacrine, 7-methoxytacrine and 6-
chlorotacrine, which were connected by various linkers. To determine the therapeutical 
potential of new compounds Ellman method was used and results were compared with 
tacrine, 7-methoxytacrine and 6-chlorotacrine as standards. The antioxidant properties of 
new derivatives were evaluated using DPPH assay with trolox as reference compound. All 
of the newly synthesized derivatives showed inhibitory activity against cholinesterases 
from micromolar to submicromolar scale. Novel hybrids also exhibited antioxidant 
activity, which was however lower than that of trolox. 
  
